Attached files
file | filename |
---|---|
EX-32 - EXHIBIT 32 - TAXUS PHARMACEUTICALS HOLDINGS, INC. | ex321.htm |
EX-31 - EXHIBIT 31 - TAXUS PHARMACEUTICALS HOLDINGS, INC. | ex312.htm |
EX-31 - EXHIBIT 31 - TAXUS PHARMACEUTICALS HOLDINGS, INC. | ex311.htm |
10-Q - FORM 10-Q - TAXUS PHARMACEUTICALS HOLDINGS, INC. | taxusholdingform10qmarch3120.htm |
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Taxus Pharmaceuticals Holdings Inc (the Company) for the quarter ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Jiayue Zhang, Chief Financial Officer of the Company, certifies that, to the best of my knowledge:
| (1) | the Report fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | all information contained in the Report fairly presents, in all material respects, the Companys financial condition and results of operations. |
Pursuant to the rules and regulations of the Securities and Exchange Commission, this certification is being furnished and is not deemed filed.
Date: May 23, 2016
| /s/ Jiayue Zhang |
| Jiayue Zhang |
| Chief Financial Officer |
| (Principal Financial Officer) |